Paul K. Whelton, MD, MSc

Dr. Paul Whelton's research interests include cardiovascular and renal disease epidemiology, prevention, clinical trials, health policy, and global health. He has led many NIH-funded blood pressure intervention trials, including the Trials of Hypertension Prevention (TOHP, Phases I and II), the Trial of Nonpharmacologic Intervention in the Elderly (TONE), the Antihypertensive and Lipid-Lowering to Prevent Heart Attack Trial (ALLHAT), and the Systolic Blood Pressure Intervention Trial (SPRINT). He chaired the 2017 ACC/AHA Guideline Writing Committee for Prevention, Detection, Evaluation, and Management of High Blood Pressure, as well as many working groups and committees for institutes at the NIH, the American Heart Association, the Institute of Medicine, the Irish Government, and the Show Chwan Health System in Taiwan. He has been supported by more than $100 million in research awards from the National Institutes of Health and published more than 600 peer-reviewed manuscripts as well as more than 100 books, book chapters, supplements, or monographs. He has held many administrative roles, including Director, Outpatient Clinical Research Center and (founding) Director, Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Medical Institutions, Dean, School of Public Health and Tropical Medicine, Dean, School of Medicine, Sr. Vice President for Health Sciences, at Tulane University, President and CEO, Loyola University Health System and Medical Center, and Sr. Vice President for the Health Sciences, Loyola University Chicago. In addition to leadership roles in many professional societies, he has served as President of the World Hypertension League.